DNA Repair Pathways and Human Metastatic Malignant Melanoma

被引:19
作者
Sarasin, A. [1 ]
Dessen, P. [1 ]
机构
[1] Univ Paris Sud, Inst Gustave Roussy, CNRS, Lab Genomes & Canc,FRE2939, F-94805 Villejuif, France
关键词
Melanoma; DNA repair; sun exposure; metastasis; cancer; NUCLEOTIDE EXCISION-REPAIR; GENETIC PREDISPOSITION; MISMATCH REPAIR; POLYMERASE-ETA; PHASE-II; CANCER; POLYMORPHISMS; EXPRESSION; CISPLATIN; RISK;
D O I
10.2174/156652410791317011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Melanoma causes a considerable public health burden because of its dramatic rise in incidence worldwide since the mid-1960s and because the metastatic disease remains incurable, has a short median survival and is characterized by resistance to almost all classes of cytotoxic agents. DNA repair pathways are multiple and are able to repair, usually in an error-free manner, all kinds of DNA damage induced by exogenous and endogenous genotoxic agents. This review describes the role of DNA repair process in protecting us from cancer and particularly nucleotide excision deficiencies that are associated with melanoma development. Resistance of tumoral cells to antitumoral regimen can be caused by overexpression of DNA repair processes. We showed that melanoma metastasis was associated with higher expression of some DNA repair pathways leading to a better surveillance of replication fork fidelity. We showed a partially coordinated regulation of these repair genes. P53 and several transcription factors may regulate numerous of these repair genes. The repair pathways that are overexpressed in metastatic melanoma are those particularly efficient in repairing the major DNA damage produced by cytotoxic treatments. This implies that better analysis of DNA repair regulation is necessary to identify novel therapeutic targets and to allow clinicians to propose tailored therapies.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 36 条
  • [31] Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma
    Tomescu, D
    Kavanagh, G
    Ha, T
    Campbell, H
    Melton, DW
    [J]. CARCINOGENESIS, 2001, 22 (03) : 403 - 408
  • [32] A gene-expression signature as a predictor of survival in breast cancer.
    van de Vijver, MJ
    He, YD
    van 't Veer, LJ
    Dai, H
    Hart, AAM
    Voskuil, DW
    Schreiber, GJ
    Peterse, JL
    Roberts, C
    Marton, MJ
    Parrish, M
    Atsma, D
    Witteveen, A
    Glas, A
    Delahaye, L
    van der Velde, T
    Bartelink, H
    Rodenhuis, S
    Rutgers, ET
    Friend, SH
    Bernards, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) : 1999 - 2009
  • [33] Van den Oord Joost J, 2007, Future Oncol, V3, P609, DOI 10.2217/14796694.3.6.609
  • [34] Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma
    Wei, QY
    Lee, JE
    Gershenwald, JE
    Ross, MI
    Mansfield, PF
    Strom, SS
    Wang, LE
    Guo, ZZ
    Qiao, YW
    Amos, CI
    Spitz, MR
    Duvic, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04) : 308 - 315
  • [35] Gene expression profiling of primary cutaneous melanoma and clinical outcome
    Winnepenninckx, VR
    Lazar, V
    Michiels, S
    Dessen, P
    Stas, M
    Alonso, SR
    Avril, MF
    Romero, PLO
    Robert, T
    Balacescu, O
    Eggermont, AMM
    Lenoir, G
    Sarasin, A
    Tursz, T
    van den Oord, JJ
    Spatz, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (07): : 472 - 482
  • [36] Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway
    Yamane, K
    Taylor, K
    Kinsella, TJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (01) : 297 - 302